Northwestern Mutual Wealth Management CO Exact Sciences Corp Transaction History

Northwestern Mutual Wealth Management CO

  • $147 Billion
  • Q3 2025

A detailed history of Northwestern Mutual Wealth Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 2,821 shares of EXAS stock, worth $189,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,821
Previous 2,793 1.0%
Holding current value
$189,091
Previous $148,000 4.05%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$40.91 - $56.0 $1,145 - $1,568
28 Added 1.0%
2,821 $154,000
Q2 2025

Aug 13, 2025
SELL
$40.31 - $58.08 $78,282 - $112,791
-1,942 Reduced 41.01%
2,793 $148,000
Q1 2025

May 14, 2025
SELL
$43.04 - $58.51 $473 - $643
-11 Reduced 0.23%
4,735 $204,000
Q4 2024

Feb 11, 2025
BUY
$49.33 - $71.97 $31,965 - $46,636
648 Added 15.81%
4,746 $266,000
Q3 2024

Nov 12, 2024
SELL
$42.43 - $70.83 $77,562 - $129,477
-1,828 Reduced 30.85%
4,098 $279,000
Q2 2024

Aug 15, 2024
SELL
$41.33 - $74.26 $524,725 - $942,804
-12,696 Reduced 68.18%
5,926 $250,000
Q1 2024

May 15, 2024
SELL
$56.27 - $73.77 $134,429 - $176,236
-2,389 Reduced 11.37%
18,622 $1.29 Million
Q4 2023

Feb 13, 2024
BUY
$59.06 - $75.72 $376,920 - $483,245
6,382 Added 43.63%
21,011 $1.55 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $33,761 - $50,708
-512 Reduced 3.38%
14,629 $997,000
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $134,511 - $203,977
2,146 Added 16.51%
15,141 $1.42 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $4,813 - $7,218
102 Added 0.79%
12,995 $881,000
Q4 2022

Feb 21, 2023
BUY
$30.35 - $53.15 $286,291 - $501,363
9,433 Added 272.63%
12,893 $638,000
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $13,651 - $21,080
427 Added 14.08%
3,460 $112,000
Q2 2022

Aug 04, 2022
SELL
$35.61 - $76.23 $36,856 - $78,898
-1,035 Reduced 25.44%
3,033 $119,000
Q1 2022

May 09, 2022
SELL
$57.56 - $82.54 $157,023 - $225,169
-2,728 Reduced 40.14%
4,068 $286,000
Q4 2021

Feb 03, 2022
SELL
$72.5 - $100.68 $130,065 - $180,619
-1,794 Reduced 20.88%
6,796 $528,000
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $143,662 - $197,487
1,592 Added 22.75%
8,590 $820,000
Q2 2021

Aug 13, 2021
BUY
$93.66 - $139.27 $353,566 - $525,744
3,775 Added 117.13%
6,998 $871,000
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $254,472 - $338,386
2,183 Added 209.9%
3,223 $425,000
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $77,396 - $110,427
777 Added 295.44%
1,040 $138,000
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $32,011 - $44,782
-439 Reduced 62.54%
263 $27,000
Q2 2020

Aug 14, 2020
SELL
$55.75 - $92.75 $72,363 - $120,389
-1,298 Reduced 64.9%
702 $61,000
Q1 2020

May 08, 2020
BUY
$37.9 - $104.44 $43,471 - $119,792
1,147 Added 134.47%
2,000 $116,000
Q4 2019

Feb 13, 2020
BUY
$77.66 - $99.74 $61,895 - $79,492
797 Added 1423.21%
853 $79,000
Q3 2019

Nov 12, 2019
SELL
$90.37 - $122.49 $58,650 - $79,496
-649 Reduced 92.06%
56 $5,000
Q2 2019

Aug 12, 2019
SELL
$89.51 - $118.04 $106,785 - $140,821
-1,193 Reduced 62.86%
705 $83,000
Q1 2019

May 10, 2019
SELL
$61.98 - $96.5 $57,269 - $89,166
-924 Reduced 32.74%
1,898 $164,000
Q3 2018

Nov 01, 2018
BUY
$48.29 - $80.6 $41,046 - $68,510
850 Added 43.1%
2,822 $223,000
Q2 2018

Aug 10, 2018
SELL
$37.84 - $69.96 $163,885 - $302,996
-4,331 Reduced 68.71%
1,972 $118,000
Q4 2017

Jan 31, 2018
SELL
$46.49 - $60.51 $27,894 - $36,306
-600 Reduced 8.69%
6,303 $331,000
Q3 2017

Nov 07, 2017
BUY
$37.05 - $47.12 $104,888 - $133,396
2,831 Added 69.52%
6,903 $325,000
Q2 2017

Aug 10, 2017
BUY
N/A
4,072
4,072 $144,000

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
164M
Call Options Held
2.2M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email